期刊文献+

HPLC法测定注射用乳糖酸阿奇霉素的有关物质 被引量:7

Determination of Related Substances in Azithromycin Lactobionate for Injection by HPLC
暂未订购
导出
摘要 目的:建立高效液相色谱法测定注射用乳糖酸阿奇霉素的有关物质。方法:采用XBridge Shield RP18柱(250 mm×4.6 mm,5μm),柱温40℃,流动相A为0.01 mol·L^(-1)无水水磷酸氢二钠溶液(用稀磷酸调节pH至8.9),流动相B为甲醇-乙腈(250:750),梯度洗脱,流速为1.0 ml·min^(-1);检测波长210 nm。结果:阿奇霉素在2.017~30.255μg·ml^(-1)范围内线性关系良好(r=0.999 9)。阿奇霉素与其降解产物在该色谱条件下能够有效分离,检测限为0.11μg·ml^(-1)。结论:该方法简便、快速、灵敏、准确,可用于测定注射用乳糖酸阿奇霉素的有关物质。 Objective:To establish a method for the determination of the related substances in azithromycin lactobionate for injection by HPLC.Method:The analysis was performed on an XBridge Shield RP18(250 mm×4.6 mm,5μm)column,the column temperature was 401,the mobile phase A was 0.01 mol·L^(-1) anhydrous disodium hydrogen phosphate solution(adjusting pH to 8.9 with dilute phosphoric acid) and the mobile phase B was composed of methanol-acetonitrile(250:750) with gradient elution at the flow rate of 1.0 ml·min^(-1).The detection wavelength was 210 nm.Result:The linear range of azithromycin was 2.017-30.255μg·ml^(-1)(r = 0.999 9).Azithromycin and its related substances could be separated completely using the developed system.The limit of detection was 0.11μg·ml^(-1).Conclusion:The method is simple,quick,sensitive,and accurate,and can be used to determine the related substances in azithromycin lactobionate for injection.
出处 《中国药师》 CAS 2013年第3期371-373,375,共4页 China Pharmacist
关键词 阿奇霉素 有关物质 高效液相色谱法 Azithromycin Related substances HPLC
  • 相关文献

参考文献10

二级参考文献43

  • 1史颖,姚国伟,马敏.反相高效液相色谱法测定阿奇霉素及其相关化合物[J].分析化学,2005,33(4):512-514. 被引量:15
  • 2陆润钟.Azithromycin及其相关化合物的分析[J].国外医药(抗生素分册),1995,16(2):87-91. 被引量:16
  • 3陈亦芳,李寨,郝凤兰,候平,李家泰.Azithromycin的体外抗菌作用[J].中国抗生素杂志,1995,20(3):178-185. 被引量:44
  • 4中国药典[S].2010年版.二部.附录ⅨJ.
  • 5国家食品药品监督管理局.化学药物杂质研究的技术指导原则[EB/OL].2005.http://www.sda.gov.cn/gsz05106/03.pdf.
  • 6ICH Q3A (R2). Impurities in New Drug Substances (Revised Guideline) [EB/OL]. http://www.ich.org/LOB/media/ MEDIA422.pdf.
  • 7ICH Q3B (R2). Impurities in New Drug Products (Revised Guideline) [EB/OL]. http://www.ich.org/LOB/media/ MEDIA421 .pdf.
  • 8FDA. ANDAs: Impurities in Drug Products [EB/OL]. http:// www.fda.gov/downloads/Drugs/GuidanceComplianceRegula torylnformation/Guidances/ucm072861 .pdf.
  • 9FDA. ANDAs: Impurities in Drug Substances [EB/OL]. http://www, fda.gov/downloads/Drugs/GuidanceCompliance RegulatoryInformation/Guidances/UCM 172002.pdf.
  • 10Hugh JC, Kenneth JN. Sample selection for analytical method development. Handbook of Isolation and Characterization of Impurities in Pharmaceuticals. Separation Science and Technology Series [M]. Vol 5, Sandiego CA USA: Academic Press, 2003: 145-164.

共引文献399

同被引文献39

引证文献7

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部